Alpha Tau Medical Ltd carries a market capitalization of 1.33B, placing it among publicly traded companies globally. Its enterprise value stands at 1.05B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.33B |
| Enterprise Value | 1.05B |
Alpha Tau Medical Ltd currently has 90.18M shares outstanding.
| Shares Outstanding | 90.18M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 25.75 |
| P/TBV Ratio | 25.75 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Alpha Tau Medical Ltd maintains a current ratio of 11.09, meaning it holds 11.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 11.09 |
| Quick Ratio | 10.66 |
| Debt / Equity | 34.39 |
| Debt / EBITDA | -0.30 |
| Interest Coverage | N/A |
| Return on Equity (ROE) | -141.68 |
| Return on Assets (ROA) | -75.51 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
| Income Tax | 175,000.00 |
| Effective Tax Rate | N/A |
Alpha Tau Medical Ltd's stock has gained approximately 242.69142% over the past 52 weeks. The 50-day moving average sits at 14.09, while the 200-day moving average is 9.76.
| Beta (5Y) | N/A |
| 52-Week Price Change | 242.69142% |
| 50-Day Moving Average | 14.09 |
| 200-Day Moving Average | 9.76 |
| Average Volume (20 Days) | N/A |
EBITDA reached -50.43M, while operating income came in at -50.43M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -50.43M |
| Pretax Income | -92.40M |
| Net Income | -92.57M |
| EBITDA | -50.43M |
| EBIT | -50.43M |
| Earnings Per Share (EPS) | -1.03 |
Alpha Tau Medical Ltd holds 100.64M in cash and equivalents against 15.15M in total debt, resulting in a net debt position of -16.19M. Total book value stands at 44.06M, with working capital of 97.20M providing operational flexibility.
| Cash & Cash Equivalents | 100.64M |
| Total Debt | 15.15M |
| Net Debt | -16.19M |
| Equity (Book Value) | 44.06M |
| Book Value Per Share | 0.49 |
| Working Capital | 97.20M |
Alpha Tau Medical Ltd posts an Altman Z-Score of 4.48, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.48 |